Review highlights potential of cancer immunotherapy plus targeted therapy
The prospect of combining genomically targeted therapies with drugs that
free the immune system to attack cancer suggests "we are finally poised
to deliver curative therapies to cancer patients," researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of Cell.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news